SPRB: Spruce Biosciences, Inc. Common Stock Company Profile & Statistics

Spruce Biosciences, Inc. Common Stock Profile

About

Spruce Biosciences Inc. is a biopharmaceutical company. It focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy which are in clinical stage. Spruce Biosciences Inc. is based in Daly City, California.

Info & Links

CEO

Javier Szwarcberg

Headquarters

611 GATEWAY BOULEVARD, SUITE 740
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

Spruce Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

4.79M

Enterprise Value

-10.66M

Enterprise Value/EBITDA(ttm)

0.21

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.96

Price to Book(mrq)

0.36

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

-1079.94%

Profit Margin(ttm)

-1205.11%

Return on Equity(ttm)

-177.45%

Return on Invested Capital(ttm)

-205.33%

Return on Assets(ttm)

-118.06%

Income Statement

Revenue(ttm)

1.30M

Revenue Per Share(ttm)

2.31

Gross Profit(ttm)

1.30M

EBITDA(ttm)³

-50.63M

Net Income Available to Common(ttm)

-48.34M

Diluted EPS(ttm)

-86.21

Share Statistics

Beta (5Y Monthly)

2.43

52-Week Change

-74.24%

S&P 500 52-Week Change

16.92%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

563.04K

Dividend Yield

0.00%

Float⁴

523.00K

% Held by Insiders

6.90%

% Held by Institutions

91.71%

Balance Sheet

Total Cash(mrq)

16.39M

Total Cash Per Share(mrq)

29.10

Total Debt(mrq)

943.00K

Total Debt/Equity(mrq)

7.15%

Current Ratio(mrq)

2.60%

Quick Ratio(mrq)

2.60%

Book Value Per Share(mrq)

23.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-36.47

Free Cash Flow(ytd)

-21.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SPRB

Spruce Biosciences, Inc. Common Stock